[Kawasaki disease and Mycoplasma pneumoniae infection].
Chemli
J
J
Hassayoun
S
S
Ketata
S
S
Ajmi
H
H
Ayeche
H
H
Zouari
N
N
Abroug
S
S
Boujaafar
N
N
Harbi
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000473:pathology; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006322:Heart Aneurysm / Q000000981:diagnostic imaging / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D009177:Mycoplasma pneumoniae / Q000276:immunology / Q000302:isolation & purification; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014463:Ultrasonography; D014664:Vasodilation
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D004917:Erythromycin; D001241:Aspirin